Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion

Relative Effectiveness of Osteoporosis Drugs for Preventing Nonvertebral Fracture

(2013) Suzanne M. Cadarette et al.   ANNALS OF INTERNAL MEDICINE

Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case–control study

(2013) Juan Erviti et al.   BMJ Open

Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled Trials

(2011) Donna M. Zulman et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish National Patient Register

(2011) Elsebeth Lynge et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish Civil Registration System

(2011) Carsten Bøcker Pedersen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis

(2010) Bo Abrahamsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effectiveness of bisphosphonate therapy in a community setting

(2008) Adrianne C. Feldstein et al.   BONE

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL